Latest & greatest articles for type 2 diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on type 2 diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on type 2 diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for type 2 diabetes

81. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial

Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial , , , , , , , , , , , , , , , , , , Collaborators, Affiliations Expand Collaborators MiTy Collaborative Group

2020 EvidenceUpdates

82. Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study Full Text available with Trip Pro

Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study - PubMed This site needs JavaScript to work (...) Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabetes Obes Metab Actions . 2020 Jul 30. doi: 10.1111/dom.14153. Online ahead of print. Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study , , , , , Affiliations Expand Affiliations 1 Division of Diabetes, University of Texas Health Science

2020 EvidenceUpdates

83. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Control Trial Full Text available with Trip Pro

Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Control Trial , , , , , , , , , , Affiliations Expand Affiliations 1 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. 2 Masaryk Hospital, Ústí nad Labem, Czech Republic. 3 Department of Paediatrics, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic. 4 CGParkin Communications, Inc., Henderson, NV. 5 Grunberger Diabetes Institute (...) Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Control Trial Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Control Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging

2020 EvidenceUpdates

84. Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials

Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search (...) Lancet Diabetes Endocrinol Actions . 2020 Sep 21;S2213-8587(20)30313-2. doi: 10.1016/S2213-8587(20)30313-2. Online ahead of print. Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials , , , , , , , , Affiliations Expand Affiliations 1 KfH Kidney Center, Munich, Germany; Friedrich Alexander University of Erlangen-Nürnberg, Erlangen, Germany. Electronic address: johannes.mann

2020 EvidenceUpdates

85. t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes

) is for continuous subcutaneous insulin delivery to manage blood glucose levels in people with type 1 diabetes. The device is up to 38% smaller than other insulin pumps and has a watertight aluminium case and shatter-resistant colour touch screen interface. The flat insulin cartridge accommodates up to 300 units of insulin. Rapid-acting insulin is delivered from the device through thin flexible tubing to a cannula placed under the skin. The infusion site is changed every 2 days to 3 days. The t:slim X2 pump can (...) litre. Control- IQ also uses activity and sleep settings. The device has a rechargeable battery, USB ports and the software can be updated remotely using t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes (MIB227) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 16a personal computer during the 4-year warranty of the pump. Patients can also upload their device data using the Diasend

2020 National Institute for Health and Clinical Excellence - Advice

86. Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index >/=27 kg/m(2) Full Text available with Trip Pro

Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index >/=27 kg/m(2) Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m 2 - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable (...) ahead of print. Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m 2 , , , , , , , , , Affiliations Expand Affiliations 1 Clinical and Experimental Endocrinology, UZ Gasthuisberg, University of Leuven, Leuven, Belgium. 2 State University of New York at Buffalo, Williamsville, New York, USA. 3 Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich, University of Tübingen, Tübingen

2020 EvidenceUpdates

87. Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Control: A Randomized Controlled Trial

. Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. 2 Centre for Biostatistics, Division of Health Sciences, University of Otago, Dunedin, New Zealand. 3 Department of Paediatrics and Child Health, University of Otago, Wellington, Wellington, New (...) Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Control: A Randomized Controlled Trial Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19

2020 EvidenceUpdates

88. Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis Full Text available with Trip Pro

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review (...) at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Original investigation Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis Kai-Cheng Chang, Shih-Chieh Shao, Shihchen Kuo, Chen-Yi

2020 Research Square

89. Effects of probiotics on glycemic control and intestinal dominant flora in patients with type 2 diabetes mellitus: A protocol of a systematic review and meta-analysis Full Text available with Trip Pro

Effects of probiotics on glycemic control and intestinal dominant flora in patients with type 2 diabetes mellitus: A protocol of a systematic review and meta-analysis Inplasy Protocol 832 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

90. The Effect of Patient Empowerment on Anxiety, Depression or Health-Related Quality of Life in Patients With Type 2 Diabetes: A Systematic Review Protocol Full Text available with Trip Pro

The Effect of Patient Empowerment on Anxiety, Depression or Health-Related Quality of Life in Patients With Type 2 Diabetes: A Systematic Review Protocol The Effect of Patient Empowerment on Anxiety, Depression or Health-Related Quality of Life in Patients With Type 2 Diabetes: A Systematic Review Protocol | Research Square Browse Tools & Services Your Cart This preprint is under consideration at Systematic Reviews . A preprint is a preliminary version of a manuscript that has not completed (...) peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Protocol The Effect of Patient Empowerment on Anxiety, Depression or Health-Related Quality of Life in Patients With Type 2 Diabetes: A Systematic Review Protocol Andrea Duarte-Díaz, Lilisbeth Perestelo-Pérez

2020 Research Square

91. Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment. (Abstract)

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment. It is thought that a reduction in the frequency of basal insulin injections might facilitate treatment acceptance and adherence among patients with type 2 diabetes. Insulin icodec is a basal insulin analogue designed for once-weekly administration that is in development for the treatment of diabetes.We conducted a 26-week, randomized, double-blind, double-dummy, phase 2 trial to investigate the efficacy and safety (...) of once-weekly insulin icodec as compared with once-daily insulin glargine U100 in patients who had not previously received long-term insulin treatment and whose type 2 diabetes was inadequately controlled (glycated hemoglobin level, 7.0 to 9.5%) while taking metformin with or without a dipeptidyl peptidase 4 inhibitor. The primary end point was the change in glycated hemoglobin level from baseline to week 26. Safety end points, including episodes of hypoglycemia and insulin-related adverse events

2020 NEJM

96. The prevalence of type 2 diabetes and prediabetes among armed forces personnel: a systematic review and meta-analysis Full Text available with Trip Pro

The prevalence of type 2 diabetes and prediabetes among armed forces personnel: a systematic review and meta-analysis The prevalence of type 2 diabetes and prediabetes among armed forces personnel: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This preprint is under consideration at BMC Public Health . A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior (...) to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The prevalence of type 2 diabetes and prediabetes among armed forces personnel: a systematic review and meta-analysis Mohammad Fathalipour, Maryam Taghdir, Soheil Hassanipour, Mojtaba Sepandi, Sepideh Abbaszadeh Mohammad Fathalipour Hormozgan University of Medical Sciences

2020 Research Square

97. A COMPARATIVE STUDY ON PERIAPICAL HEALING FOLLOWED BY ENDODONTIC THERAPY IN TYPE II DIABETES MELLITUS VS NON –DIABETES-A SYSTEMATIC REVIEW Full Text available with Trip Pro

occurrence of apical periodontitis in diabetes mellitus patients. The healing process of periapical tissue in diabetes is affected by the altered immunity. The aim of the study is to determine the periapical healing followed by endodontic therapy in type 2 diabetes mellitus and compare with non-diabetes Methodology: This review was directed as per the PRISMA and JBI guidelines. A total of six articles published over a period of past 15 years were included in qualitative synthesis. Results: Total of 1424 (...) A COMPARATIVE STUDY ON PERIAPICAL HEALING FOLLOWED BY ENDODONTIC THERAPY IN TYPE II DIABETES MELLITUS VS NON –DIABETES-A SYSTEMATIC REVIEW A COMPARATIVE STUDY ON PERIAPICAL HEALING FOLLOWED BY ENDODONTIC THERAPY IN TYPE II DIABETES MELLITUS VS NON –DIABETES-A SYSTEMATIC REVIEW | International Journal of Medical Science And Diagnosis Research Search / / / Articles Keywords: Type II diabetes mellitus, Non- Diabetes, Root Canal Therapy, Periapical Healing Abstract Introduction: There is high

2020 International Journal of Medical Science And Diagnosis Research

98. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study. (Abstract)

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors could increase the risk for diabetic ketoacidosis (DKA).To assess whether SGLT-2 inhibitors, compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, are associated with an increased risk for DKA in patients with type 2 diabetes.Population-based cohort study; prevalent new-user design between 2013 and 2018. (ClinicalTrials.gov (...) : NCT04017221).Electronic health care databases from 7 Canadian provinces and the United Kingdom.208 757 new users of SGLT-2 inhibitors were matched by using time-conditional propensity scores to 208 757 recipients of DPP-4 inhibitors.Cox proportional hazards models estimated site-specific hazard ratios (HRs) with 95% CIs of DKA comparing receipt of SGLT-2 inhibitors with receipt of DPP-4 inhibitors, which were pooled by using random-effects models. Secondary analyses were stratified by molecule, age, sex

2020 Annals of Internal Medicine

99. Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis Full Text available with Trip Pro

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer (...) review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Original investigation Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis Elvira D'Andrea, Aaron S. Kesselheim

2020 Research Square

100. Effectiveness of dietetic intervention for people with type 2 diabetes: a meta-analysis Full Text available with Trip Pro

Effectiveness of dietetic intervention for people with type 2 diabetes: a meta-analysis Effectiveness of dietetic intervention for people with type 2 diabetes: a meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its (...) validity or suitability for dissemination as established information or for guiding clinical practice. Original investigation Effectiveness of dietetic intervention for people with type 2 diabetes: a meta-analysis George Siopis, Stephen Colagiuri AO, Margaret Allman-Farinelli George Siopis The University of Sydney Corresponding Author ORCiD: https://orcid.org/0000-0003-1407-0846 Stephen Colagiuri AO University of Sydney Margaret Allman-Farinelli University of Sydney DOI: License: This work is licensed

2020 Research Square